April 18, 2016
Kite Pharma Commends Scientific Advisory Board Members on Awards Received from the American Association of Cancer Research (AACR)
Antoni Ribas, M.D., Ph.D., is receiving the Richard and Hinda RosenthalMemorial Award for his clinical research leading to improved treatments for patients with metastatic melanoma. Dr. Ribasis Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles(UCLA), Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center(JCCC) and the Chair of the Melanoma Committee at SWOG. Dr. Ribashad a seminal role in the development of BRAF and PD-1 inhibitors for melanoma, leading to the approval of several new treatments for this disease. The award lecture will focus on Dr. Ribas' studies elucidating the mechanisms of resistance to anti-PD-1 checkpoint immunotherapy. Dr. Ribasis the second member of Kite's SABto receive this prestigious award. Owen Witte, M.D., Chairman of Kite's SAB, received this award in 1991. The award lecture will be held during the AACR Conferenceon Monday, April 18, in the Morial Convention Center.
Ronald Levy, M.D., is receiving the Lloyd J. Old Award in Cancer Immunology for the impact his innovative research has made in cancer immunology. Dr. Levyis the Robert K. Summy and Helen K. Summy Professorof Medicine and Director of the Lymphoma Program at Stanford University School of Medicine. He is also the Associate Director of Translational Science for the Stanford Cancer Institute. For more than 25 years, his research has focused on monoclonal antibodies and the study of malignant lymphoma, currently using the tools of immunology and molecular biology to develop a better understanding of the initiation and progression of the malignant process. Dr. Levyis the second member of Kite's SABto receive this honor. James P. Allison, Ph.D., received this award in 2013. The award lecture will be held during the AACR Conferenceon Tuesday, April 19, in the Morial Convention Center.
"We are extremely proud of our
Greg MannVP, Investor Relations email@example.com For Media: Justin Jackson Burns McClellan(212) 213-0006 firstname.lastname@example.org
News Provided by Acquire Media